Nestlé has completed the $11.85bn acquisition of Pfizer Nutrition, following the conclusion of the regulatory process in most markets.
Pfizer Nutrition complements Nestlé's existing portfolio with brands in key segments and geographies. It will enhance Nestlé's infant nutrition business, building on its growth-focused strategy, global presence and research & development.
Nestlé will be able to combine brands like S-26 Gold, SMA and Promil with its existing portfolio of brands such as Nan, Gerber, Lactogen, Nestogen and Cerelac infant cereal.
The integration process will result in around 4,500 Pfizer Nutrition employees joining the Nestlé Group.
The regulatory approval process is still underway in Kenya, South Africa and five Latin American countries.
